| Product Code: ETC5358968 | Publication Date: Nov 2023 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
In the Austria buprenorphine market, the import trend exhibited significant growth from 2023 to 2024, with a notable increase of 42.75%. The compound annual growth rate (CAGR) for the period 2020-2024 stood at 19.27%. This import momentum can be attributed to shifting demand dynamics and evolving market stability within the sector.

By 2027, the Buprenorphine market in Austria is anticipated to reach a growth rate of 0.06%, as part of an increasingly competitive Europe region, where Germany remains at the forefront, supported by United Kingdom, France, Italy and Russia, driving innovations and market adoption across sectors.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Austria Buprenorphine Market Overview |
3.1 Austria Country Macro Economic Indicators |
3.2 Austria Buprenorphine Market Revenues & Volume, 2022 & 2032F |
3.3 Austria Buprenorphine Market - Industry Life Cycle |
3.4 Austria Buprenorphine Market - Porter's Five Forces |
3.5 Austria Buprenorphine Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.6 Austria Buprenorphine Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Austria Buprenorphine Market Revenues & Volume Share, By Distribution Channel, 2022 & 2032F |
4 Austria Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of opioid addiction in Austria |
4.2.2 Growing awareness and acceptance of buprenorphine as an effective treatment for opioid dependence |
4.2.3 Government initiatives to expand access to opioid addiction treatment services |
4.2.4 Advancements in buprenorphine formulations and delivery methods |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for prescribing and dispensing buprenorphine |
4.3.2 Limited availability of healthcare professionals trained in buprenorphine treatment |
4.3.3 Stigma associated with medication-assisted treatment for opioid addiction |
4.3.4 High cost of buprenorphine treatment for patients without insurance coverage |
5 Austria Buprenorphine Market Trends |
6 Austria Buprenorphine Market Segmentations |
6.1 Austria Buprenorphine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Austria Buprenorphine Market Revenues & Volume, By Analgesic, 2022-2032F |
6.1.3 Austria Buprenorphine Market Revenues & Volume, By Opioid Antagonist, 2022-2032F |
6.2 Austria Buprenorphine Market, By Route of Administration |
6.2.1 Overview and Analysis | 6.2.2 Austria Buprenorphine Market Revenues & Volume, By Injectables, 2022-2032F |
6.2.3 Austria Buprenorphine Market Revenues & Volume, By Sublingual, 2022-2032F |
6.2.4 Austria Buprenorphine Market Revenues & Volume, By Transdermal Patches, 2022-2032F |
6.3 Austria Buprenorphine Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Austria Buprenorphine Market Revenues & Volume, By Hospital Pharmacies, 2022-2032F |
6.3.3 Austria Buprenorphine Market Revenues & Volume, By Retail Pharmacies, 2022-2032F |
6.3.4 Austria Buprenorphine Market Revenues & Volume, By Online Pharmacies, 2022-2032F |
7 Austria Buprenorphine Market Import-Export Trade Statistics |
7.1 Austria Buprenorphine Market Export to Major Countries |
7.2 Austria Buprenorphine Market Imports from Major Countries |
8 Austria Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare providers authorized to prescribe buprenorphine |
8.2 Patient retention rates in buprenorphine treatment programs |
8.3 Rate of successful treatment outcomes with buprenorphine therapy |
8.4 Number of public health campaigns promoting the benefits of buprenorphine therapy |
8.5 Adoption rate of new buprenorphine formulations or delivery methods |
9 Austria Buprenorphine Market - Opportunity Assessment |
9.1 Austria Buprenorphine Market Opportunity Assessment, By Application, 2022 & 2032F |
9.2 Austria Buprenorphine Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Austria Buprenorphine Market Opportunity Assessment, By Distribution Channel, 2022 & 2032F |
10 Austria Buprenorphine Market - Competitive Landscape |
10.1 Austria Buprenorphine Market Revenue Share, By Companies, 2025 |
10.2 Austria Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here